Pancreatic ß-cell fate in subjects with COVID-19.

Shirakawa, Jun

Shirakawa, Jun.

Shirakawa J; Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan.

J Diabetes Investig ; 12(12): 2126-2128, 2021 Dec.

Article in English | MEDLINE | ID: covidwho-1413728

ABSTRACT

ABSTRACT

Two recent reports denoted the potential of SARS-CoV-2 to directly infect ß-cells and the possible fate of ß-cells under COVID-19. The fight against SARS-CoV-2 will continue to develop more effective therapeutic strategies for diabetes.

Subject(s)

COVID-19/epidemiology; COVID-19/metabolism; Diabetes Mellitus/epidemiology; Diabetes Mellitus/metabolism; Insulin-Secreting Cells/metabolism; SARS-CoV-2/metabolism; Diabetes Mellitus/virology; Humans; Insulin-Secreting Cells/virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / Insulin-Secreting Cells / SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Diabetes Investig Year: 2021 Document Type: Article Affiliation country: Jdi.13671

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google